In Crohn’s disease, nucleotide-binding oligomerization domain (NOD) 2 (NOD2), the first identified susceptibility gene, is also reduced by nicotine in HT29 cells when treated by TNF-α, implying the potential anti-inflammatory effect of nicotine on Crohn’s disease (46). Here, TNF is linked to Crohn disease.